Study of HuMab-5B1 (MVT-5873) in Subjects With Pancreatic Cancer or Other Cancer Antigen 19-9 (CA19-9) Positive Malignancies

Stopped early · Phase 1

Conditions studied: Pancreatic Cancer

In brief

Phase 1 Safety and Tolerability Study in Subjects with Pancreatic Cancer or Other CA19-9 Positive Malignancies.

Key facts

Study ID

NCT02672917

Run by

BioNTech Research & Development, Inc.

People needed

118

Starts

2016-01-01

Expected to finish

2025-01-14

Last updated by the study team

2025-01-28

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• HonorHealth Research Institute — Scottsdale, Arizona, United States
• The Angeles Clinic & Research Institute — Los Angeles, California, United States
• Florida Cancer Specialist and Research Institute — Sarasota, Florida, United States
• MSKCC — New York, New York, United States
• Sarah Cannon Research Institute — Nashville, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.